Retraction notice to: Effect of thioredoxin-interacting protein on Wnt/β-catenin signaling pathway and diabetic myocardial infarction [Asian Pac J Trop Med 8(11) (2015) 976–982] (S1995764515001674) (10.1016/j.apjtm.2015.10.010));Effect of thioredoxin-interacting protein on Wnt/β-catenin signaling pathway and diabetic myocardial infarction

Asian Pacific Journal of Tropical Medicine

Volumn 8, Issue 11, 2015, Pages 976-982

  Yu, Hui ^a   Zhao, Xian Xian ^a   Shan, Xing Hua ^a   Li, Pan ^a   Chen, Tao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Myocardial infarction; Thioredoxin interacting protein; catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; GLUCOSE; MYC PROTEIN; REACTIVE OXYGEN METABOLITE; THIOREDOXIN INTERACTING PROTEIN; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

EID: 84947907574     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apjtm.2017.06.014     Document Type: Erratum

References (26)

1. Benford M., Milligan G., Pike J., Anderson P., Piercy J., Fermer S. Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance. Adv Ther 2012, 29(1):26-40.
2. Nasri H. On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view. J Renal Inj Prev 2013, 2(2):31-32.
3. Sun S.N., Zhao W.G., Dong Y.Y., Li Z. The current status and influential factors of self-management in diabetic patients. Chin J Nurs 2011, 46(3):229-233.
4. van Dieren S., Beulens J.W., Kengne A.P., Peelen L.M., Rutten G.E., Woodward M., et al. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart 2012, 98(5):360-369.
5. Parving H.H., Brenner B.M., McMurray J.J., de Zeeuw D., Haffner S.M., Solomon S.D., et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 2012, 367(23):2204-2213.
6. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diab Care 2014, 27(Suppl 1):S5-S10.
7. Schramm T.K., Gislason G.H., Vaag A., Rasmussen J.N., Folke F., Hansen M.L., et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J 2011, 32(15):1900-1908.
8. Meier P., Hemingway H., Lansky A.J., Knapp G., Pitt B., Seiler C. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J 2012, 33(5):614-621.
9. Calleja A.I., Cortijo E., García-Bermejo P., Gómez R.D., Pérez-Fernández S., Del Monte J.M., et al. Collateral circulation on perfusion-computed tomography-source images predicts the response to stroke intravenous thrombolysis. Eur J Neurol 2013, 20(5):795-802.
10. Söğüt E., Kadi H., Karayakali M., Mertoğlu C. The association of plasma vitamin A and E levels with coronary collateral circulation. Atherosclerosis 2015, 239(2):547-551.
11. Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell 2012, 149(6):1192-1205.
12. Chen B.Y., Wang X., Wang Z.Y., Wang Y.Z., Chen L.W., Luo Z.J. Brain-derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/β-catenin signaling pathway. J Neurosci Res 2013, 91(1):30-41.
13. Buikema J.W., Zwetsloot P.P.M., Doevendans P.A., Domian I.J., Sluijter J.P.G. Wnt/β-catenin signaling during cardiac development and repair. J Cardiovasc Dev Dis 2014, 1(1):98-110.
14. Leibowitz G., Ktorza A., Cerasi E. The role of TXNIP in the pathophysiology of diabetes and its vascular complications: a concise review. Medicographia 2014, 36(3):391-397.
15. Kolluru G.K., Bir S.C., Kevil C.G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012, 2012:918267.
16. Hwang J., Suh H.W., Jeon Y.H., Hwang E., Nguyen L.T., Yeom J., et al. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Nat Commun 2014, 5:2958.
17. Shah Anu, Xia Ling, Fantus I.G. The role of thioredoxin-interacting protein (TXNIP) in the development of diabetic nephropathy. Can J Diab 2013, 37(Suppl 4):S9.
18. Chai T.F., Hong S.Y., He H., Zheng L., Hagen T., Luo Y., et al. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression. Cell Signal 2012, 24(8):1700-1705.
19. Aisagbonhi O., Rai M., Ryzhov S., Atria N., Feoktistov I., Hatzopoulos A.K. Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech 2011, 4(4):469-483.
20. Laeremans H., Hackeng T.M., van Zandvoort M.A., Thijssen V.L., Janssen B.J., Ottenheijm H.C., et al. Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 2011, 124(15):1626-1635.
21. Brunt K.R., Zhang Y., Mihic A., Li M., Li S.H., Xue P., et al. Role of wnt/β-catenin signaling in rejuvenating myogenic differentiation of aged mesenchymal stem cells from cardiac patients. Am J Pathol 2012, 181(6):2067-2078.
22. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012, 24(5):981-990.
23. Hulsmans M., Van Dooren E., Holvoet P. Mitochondrial reactive oxygen species and risk of atherosclerosis. Curr Atheroscler Rep 2012, 14(3):264-276.
24. Huynh K., Kiriazis H., Du X.J., Love J.E., Gray S.P., Jandeleit-Dahm K.A., et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radic Biol Med 2013, 60:307-317.
25. Devi T.S., Hosoya K., Terasaki T., Singh L.P. Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy. Exp Cell Res 2013, 319(7):1001-1012.
26. Yoshioka J., Lee R.T. Thioredoxin-interacting protein and myocardial mitochondrial function in ischemia-reperfusion injury. Trends Cardiovasc Med 2014, 24(2):75-80.